» Articles » PMID: 34765438

Successful Allogeneic Bone Marrow Transplantation After Massive Gastrointestinal Bleeding in a Patient with Myelodysplastic Syndrome Associated with Intestinal Behçet-like Disease

Abstract

A 45-year-old woman was diagnosed with myelodysplastic syndrome (MDS) with trisomy 8 and Behçet-like disease (BLD) with multiple colorectal ulcers. Nonspecific inflammatory cells were infiltrated in the intestinal mucosa, whereas fluorescence in situ hybridization (FISH) analysis revealed only sporadic trisomy 8-positive cells. She presented massive lower gastrointestinal bleeding early after bone marrow transplantation but achieved long-term remission of both MDS and BLD. This is the first report of massive gastrointestinal bleeding after transplantation for MDS with BLD. Based on FISH analysis, dysregulation of systemic inflammation may be involved in BLD rather than direct invasion by trisomy 8-positive MDS clones.

Citing Articles

Application of allogeneic hematopoietic stem cell transplantation to treat Behcet's disease with myelodysplastic syndrome: a case report and literature review.

Lei R, Liu X, Wu Y, Song J, Lv X, Liu J Ann Hematol. 2024; 103(12):6015-6020.

PMID: 39611877 DOI: 10.1007/s00277-024-06122-y.

References
1.
Yilmaz U, Ar M, Esatoglu S, Bavunoglu I, Erzin Y, Hatemi A . How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review. Ann Hematol. 2020; 99(6):1193-1203. DOI: 10.1007/s00277-020-03951-5. View

2.
Asano T, Sato S, Furuya M, Takahashi H, Shichishima-Nakamura A, Ohkawara H . Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report. Medicine (Baltimore). 2019; 98(46):e17979. PMC: 6867715. DOI: 10.1097/MD.0000000000017979. View

3.
Hatemi G, Christensen R, Bang D, Bodaghi B, Celik A, Fortune F . 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018; 77(6):808-818. DOI: 10.1136/annrheumdis-2018-213225. View

4.
Noguchi M, Moritake H, Kamimura S, Sonoda M, Ishimura M, Inagaki J . Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome. Bone Marrow Transplant. 2018; 53(9):1214-1217. DOI: 10.1038/s41409-018-0180-y. View

5.
Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M . Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol. 2003; 21(10):1988-95. DOI: 10.1200/JCO.2003.10.503. View